Similarly, many other studies have reported that LBP reduces the body's inflammatory response through NF-κB and MAPK signaling pathways (Qi et al., 2022; Sun et al., 2023; Jiang et al., 2023). This evidence concerns the gene NFKB1 and Low back pain.